Show simple item record

dc.contributor.authorGollins, S
dc.contributor.authorSun Myint, A
dc.contributor.authorHaylock, Brian
dc.contributor.authorWise, M
dc.contributor.authorSaunders, Mark P
dc.contributor.authorNeupane, R
dc.contributor.authorEssapen, S
dc.contributor.authorSamuel, L
dc.contributor.authorDougal, Mark
dc.contributor.authorLloyd, A
dc.contributor.authorMorris, J
dc.contributor.authorTopham, C
dc.contributor.authorSusnerwala, S
dc.date.accessioned2012-01-09T22:34:52Z
dc.date.available2012-01-09T22:34:52Z
dc.date.issued2011-03-10
dc.identifier.citationPreoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes. 2011, 29 (8):1042-9 J. Clin. Oncol.en
dc.identifier.issn1527-7755
dc.identifier.pmid21263095
dc.identifier.doi10.1200/JCO.2010.29.7697
dc.identifier.urihttp://hdl.handle.net/10541/201090
dc.description.abstractTo assess long-term clinical outcomes of preoperative chemoradiotherapy of magnetic resonance imaging (MRI)-defined locally advanced rectal adenocarcinoma using concurrent irinotecan and capecitabine.
dc.language.isoenen
dc.subject.meshAdenocarcinoma
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.subject.meshCamptothecin
dc.subject.meshChemotherapy, Adjuvant
dc.subject.meshChi-Square Distribution
dc.subject.meshDeoxycytidine
dc.subject.meshDisease-Free Survival
dc.subject.meshFemale
dc.subject.meshFluorouracil
dc.subject.meshGreat Britain
dc.subject.meshHumans
dc.subject.meshKaplan-Meier Estimate
dc.subject.meshMagnetic Resonance Imaging
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNeoadjuvant Therapy
dc.subject.meshNeoplasm Invasiveness
dc.subject.meshNeoplasm Recurrence, Local
dc.subject.meshProportional Hazards Models
dc.subject.meshRadiation Dosage
dc.subject.meshRadiotherapy, Adjuvant
dc.subject.meshRectal Neoplasms
dc.subject.meshRisk Assessment
dc.subject.meshRisk Factors
dc.subject.meshTime Factors
dc.subject.meshTreatment Outcome
dc.titlePreoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.en
dc.typeArticleen
dc.contributor.departmentDepartment of Clinical Oncology, North Wales Cancer Treatment Centre, Rhyl, LL18 5UJ United Kingdom.en
dc.identifier.journalJournal of Clinical Oncologyen
html.description.abstractTo assess long-term clinical outcomes of preoperative chemoradiotherapy of magnetic resonance imaging (MRI)-defined locally advanced rectal adenocarcinoma using concurrent irinotecan and capecitabine.


This item appears in the following Collection(s)

Show simple item record